| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Senior Vice President, Finance
1 company
Catinazzo Thomas is a Chief Financial Officer at Relay Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 19,517 | $13.19 | $257,498.17 | -4.4% | - | - | |
| Mar 9, 2026 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 17,717 | $10.06 | $178,233.02 | -7.1% | - | - | |
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 15,515 | $7.71 | $119,631.15 | -3.0% | +70.3% | - | |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 21,664 | $7.29 | $157,930.56 | -6.5% | +0.9% | - | |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 20,081 | $3.69 | $74,000.14 | -2.8% | +103.9% | - | |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 19,191 | $3.07 | $58,848.64 | -1.3% | +8.7% | +289.2% | |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 4,864 | $2.84 | $13,813.76 | -0.6% | +9.0% | +221.1% | |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 58,936 | $4.55 | $268,338.85 | -4.3% | -26.7% | +68.7% | |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 4,865 | $4.42 | $21,491.34 | -0.8% | -31.4% | +96.3% | |
| Oct 29, 2024 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sell | 9,102 | $6.03 | $54,905.12 | -1.0% | -20.0% | +23.9% |